These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16503077)

  • 61. Imaging techniques for hepatocellular carcinoma.
    Sirlin C
    Clin Adv Hematol Oncol; 2015 Jun; 13(6):359-61. PubMed ID: 26352891
    [No Abstract]   [Full Text] [Related]  

  • 62. Surgically resected hepatocellular carcinoma: protean yet predictable.
    Vauthey JN; Lauwers GY
    Ann Surg Oncol; 2005 Apr; 12(4):270-2. PubMed ID: 15827674
    [No Abstract]   [Full Text] [Related]  

  • 63. The model for end-stage liver disease based cancer staging systems are better prognostic models for hepatocellular carcinoma: a prospective sequential survey.
    Huo TI; Lin HC; Hsia CY; Wu JC; Lee PC; Chi CW; Lee SD
    Am J Gastroenterol; 2007 Sep; 102(9):1920-30. PubMed ID: 17573792
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Treatment of hepatocellular carcinoma.
    Forner A; Hessheimer AJ; Isabel Real M; Bruix J
    Crit Rev Oncol Hematol; 2006 Nov; 60(2):89-98. PubMed ID: 16860993
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evaluation of new prognostic staging systems (SLiDe score) for hepatocellular carcinoma patients who underwent hepatectomy.
    Nanashima A; Omagari K; Sumida Y; Abo T; Fukuoha H; Takeshita H; Hidaka S; Tanaka K; Sawai T; Yasutake T; Nagayasu T; Mizuta Y; Ohba K; Ohnita K; Kadokawa Y
    Hepatogastroenterology; 2009; 56(93):1137-40. PubMed ID: 19760957
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prognostic value and clinical relevance of the 6th Edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinoma.
    Lei HJ; Chau GY; Lui WY; Tsay SH; King KL; Loong CC; Wu CW
    J Am Coll Surg; 2006 Oct; 203(4):426-35. PubMed ID: 17000385
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellular carcinoma.
    Reddy MS; Manas DM
    Transplantation; 2007 Feb; 83(3):367-8. PubMed ID: 17297420
    [No Abstract]   [Full Text] [Related]  

  • 68. Sustained complete response and low complication rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis.
    Cho YK; Kim JK
    Hepatology; 2008 May; 47(5):1791; author reply 1791. PubMed ID: 18393364
    [No Abstract]   [Full Text] [Related]  

  • 69. A simple prognostic scoring system for patients with unresectable hepatocellular carcinoma treated by chemo-embolization.
    Dvorchik I; Carr BI
    Cancer Detect Prev; 2007; 31(2):154-60. PubMed ID: 17416468
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Percutaneous liver biopsy in the clinical management of hepatocellular carcinoma: back to the future.
    Colecchia A; Montrone L; Scaioli E; Festi D
    Hepatology; 2011 Jun; 53(6):2147. PubMed ID: 21472742
    [No Abstract]   [Full Text] [Related]  

  • 71. Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma.
    Pang JZ; Qin LX; Ren N; Hei ZY; Ye QH; Jia WD; Sun BS; Lin GL; Liu DY; Liu YK; Tang ZY
    Clin Cancer Res; 2007 Dec; 13(24):7363-9. PubMed ID: 18094418
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Staging for hepatocellular carcinoma: complex and confusing.
    Sherman M
    Gastroenterology; 2014 Jun; 146(7):1599-602. PubMed ID: 24780213
    [No Abstract]   [Full Text] [Related]  

  • 73. Current treatment strategy for hepatocellular carcinoma.
    Ng KK; Poon RT
    Saudi Med J; 2007 Sep; 28(9):1330-8. PubMed ID: 17768455
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hepatocellular carcinoma.
    Ahn J; Flamm SL
    Dis Mon; 2004 Oct; 50(10):556-73. PubMed ID: 15616490
    [No Abstract]   [Full Text] [Related]  

  • 75. Down-staging of hepatocellular carcinoma before liver transplantation: should we change our clinical practice?
    Ravaioli M; Grazi GL; Cescon M; Ercolani G; Pinna AD; Piscaglia F; Trevisani F
    Ann Surg; 2009 Aug; 250(2):348; author reply 348-9. PubMed ID: 19638902
    [No Abstract]   [Full Text] [Related]  

  • 76. Hepatocellular carcinoma: have we finally found the ultimate staging system for HCC?
    Chapiro J; Geschwind JF
    Nat Rev Gastroenterol Hepatol; 2014 Jun; 11(6):334-6. PubMed ID: 24798199
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [The treatment of hepatocellular carcinoma: an update].
    Vero V; Racco S; Biolato M; Pompili M; Gasbarrini G; Miele L; Grieco A
    Minerva Med; 2009 Jun; 100(3):173-93. PubMed ID: 19571783
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Transarterial chemoembolization for hepatocellular carcinoma with portal vein invasion: a helpful palliative approach.
    Schumacher G; Gebauer B
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1317-9. PubMed ID: 19702898
    [No Abstract]   [Full Text] [Related]  

  • 79. [Clinicopathological studies in patients with hepatocellular carcinoma. V. Analysis of the numbers of parameters for prognosis forecasting (author's transl)].
    Nishioka M; Nawata J; Kan T; Kan M; Takemoto T; Fukuda T; Miyaji T
    Rinsho Byori; 1981 Mar; 29(3):309-11. PubMed ID: 6267338
    [No Abstract]   [Full Text] [Related]  

  • 80. [Key issues and prospects for the study on metastasis of hepatocellular carcinoma].
    Tang ZY
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1601. PubMed ID: 19094748
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.